Horizon Therapeutics Public Ltd Co

ABRAMS CAPITAL MANAGEMENT, L.P.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

890,993

Value ($000)

91,639

Weight

2.6%

2023 Q2 - 2023 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	91,639	2.6%	890,993	6/30/2023